Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Articles published by RION

News headline image
INTENT Biologics Receives FDA Fast Track Designation for PEP Biologic™
From RION
Via Business Wire
News headline image
CORRECTING and REPLACING RION Launches RION Vet to Transform Animal Health with First-in-Class Biologic Therapeutic; Appoints Industry Leader Mark Herthel as CEO; Announces Series A Fulfillment
From RION
Via Business Wire
News headline image
RION Engages Lonza to Scale Manufacturing Exosome Based Therapeutics
From RION
Via Business Wire
News headline image
RION Launches INTENT Biologics to Develop Late-Stage Clinical Exosome-Based Therapies in Inflammation & Immunology; Appoints Biopharma Veteran Suneet Varma as CEO
From RION
Via Business Wire
News headline image
RION names Biopharma Veteran Suneet Varma as Senior Advisor to Spearhead Expansion into Regenerative Therapeutics
From RION
Via Business Wire
News headline image
RION Announces First Patient Enrolled in Phase 1b Clinical Study Evaluating Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
From RION
Via Business Wire
News headline image
RION Announces Final Patient Enrolled in the Phase 2 Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
From RION
Via Business Wire
News headline image
RION to Present at the 43rd Annual J.P. Morgan Healthcare Conference
From RION
Via Business Wire
News headline image
RION Expands Leadership Team with the Appointment of Five Renowned Experts to Advisory Boards
From RION
Via Business Wire
News headline image
RION Announces Initiation of Phase 1b Clinical Study to Evaluate Purified Exosome Product™ (PEP™) for Knee Osteoarthritis
From RION
Via Business Wire
News headline image
RION Announces First Patient Dosed in Phase 2 Clinical Study of Purified Exosome Product™ for Diabetic Foot Ulcers
From RION
Via Business Wire
News headline image
RION Expands Manufacturing Operations with Cutting-Edge Facility in Rochester, Minnesota
From RION
Via Business Wire
News headline image
RION Announces Initiation of Phase 2A Clinical Study for Purified Exosome Product™ (PEP™) in Diabetic Foot Ulcers
From RION
Via Business Wire
News headline image
Rion to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Rion
Via Business Wire
News headline image
RION, Mayo Clinic, and the U.S. Army Medical Research Institute for Chemical Defense Receive $2.4M Department of Defense Award to Advance Exosome-Based Research in Pulmonary Therapeutics
From RION
Via Business Wire
News headline image
RION Announces the Advisory Appointments of John Ballantyne, Ph.D., to Chair of the Rion Scientific Advisory Board and Andrew D. Badley, M.D., to Chair of the Rion Medical Advisory Board
From RION
Via Business Wire
News headline image
RION Appoints Alisa Lask as Chief Commercial Officer
From RION
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.